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Abstract
Background: The recent drive towards accreditation of clinical laboratories in Africa by the World Health Organization –
Regional Office for Africa (WHO-AFRO) and the U.S Government is a historic step to strengthen health systems, provide
better results for patients and an improved quality of results for clinical trials. Enrollment in approved proficiency testing
(PT) programs and maintenance of satisfactory performance is vital in the process of accreditation. Passing proficiency
testing surveys has posed a great challenge to many laboratories across sub-Saharan Africa. Our study was aimed at
identifying the causes of unsatisfactory PT results in clinical research laboratories conducting or planning to conduct malaria
vaccine trials sponsored by the National Institutes of Health (NIH).
Methodology: PT reports for 2009 and 2010 from the College of American Pathologists (CAP) for the laboratories were
reviewed as part of the process. Errors accounting for unsatisfactory results were classified into clerical, methodological,
technical, problem with PT materials, and random errors. A training program on good clinical laboratory practices (GCLP)
was developed for each center to address areas for improvement.
Results: The major cause of PT failure in the four centers was methodological. The application of GCLP improved the
success rate in the PT surveys from 58% in 2009 to 88% in 2010. It also decreased the error rate on PT by 35%.
Conclusion: A previous report from the CAP- PT participating laboratories indicated that the major causes of error were
clerical. These types of errors were predominantly made in laboratories in the US, with much more experience in quality
control, and varied significantly from what we found. In our centers in sub-Saharan Africa, methodological errors, and not
clerical errors, accounted for the vast majority of errors. A process was started for continuous improvement which has
decreased methodological errors by 35%, but more improvement is needed.
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Introduction
There are, currently, a large number of clinical drugs and
vaccines trials being conducted in developing countries [1].
Sponsors often face difficulties in maintaining quality system
activities in resource limited settings, and in locations where there
are no official government or laboratory network standards, and
no third party responsible for inspections to maintain compliance
[1]. Laboratory auditing by monitors focused on compliance with
standard operating procedures (SOPs), will only reflect a ‘‘snap
shot’’ appraisal rather than providing continuous training and
improvement of day to day activities [2].
The recent drive towards accreditation of laboratories in
developing countries by the World Health Organization Regional
Office for Africa (WHO-AFRO) [3] is a historic step to strengthen
health systems, provide better results for patients, and improve the
quality of results for clinical drugs and vaccines trials. Laboratories
across Africa are making progress with the WHO-AFRO step-wise
approach toward accreditation. Factors that contribute to a
successful accreditation project are implementation of Good
Clinical Laboratory Practices (GCLP) and the application of a
Quality Management System. This includes the enrollment in
approved proficiency testing (PT) programs and maintenance of
satisfactory performance.
In addition to the provision of equipment from the developed
countries, a resolute effort should be made to provide ‘‘hands-on’’
training to maintain a quality system [2]. Over the past few years,
the Division of Microbiology and Infectious Disease (DMID) of the
National Institutes of Health (NIH) in the United States has been
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working toward improving the performance of clinical research
laboratories of institutions conducting NIH-sponsored clinical
trials to ensure that results generated from studies will be reliable
and acceptable to regulatory bodies. The ultimate goal of the
Quality Assurance/Quality Control (QA/QC) activities described
in this paper is to achieve compliance with the College of
American Pathologists (CAP) and WHO-AFRO checklists in
preparation for accreditation through the implementation of
GCLP and the improvement of PT performance.
In PT or External Quality Assessment (EQA), samples are sent
out periodically to registered laboratories to be analyzed and/or
identified. Results from each laboratory are compared with those
of the other participating laboratories in the group [4,5] for
quantitative results like creatinine concentration, or with a pre-
determined correct response for qualitative answers such as blood
parasite identification. Among other benefits, PT enhances patient
care and safety through improved laboratory practice, helps in
identifying clinical laboratories that are at risk of performing
poorly, and satisfies accreditation and regulatory requirements [5].
Individual laboratories can use PT as an aid to a continual
improvement process, by analyzing any substandard results and
instituting corrective actions.
The laboratories of the Noguchi Memorial Institute for Medical
Research (NMIMR), Navrongo Health Research Center (NHRC)
and Kintampo Health Research Center (KHRC) (all in Ghana)
and the Center National de Recherche et de Formation sur le
Paludisme (CNRFP) in Burkina Faso have been collaborating with
the DMID in epidemiological studies and/or vaccine trials. These
laboratories have been registered with the CAP for hematology,
clinical chemistry and blood parasite surveys as a step towards
continual improvement and accreditation. However, the labora-
tories had difficulties in consistently obtaining satisfactory scores at
the beginning. Our aim was to identify the causes of unsatisfactory
scores in the CAP PT surveys and to put in place measures to
address these causes to improve performance in subsequent
surveys.
Methods
A QA/QC advisor was hired in September 2009 by the U.S
Naval Medical Research Unit No. 3 to coordinate the activities of
all four trial centers. All PT results obtained in 2009 by the trial
centers for General Chemistry, Hematology and Blood Parasites
were reviewed, retrospectively. A standardized form was distrib-
uted to assist the centers with the investigational process (Table 1)
[6]. PT failures were classified into five main categories: clerical,
methodological, technical, PT materials stability, and random
errors, according to criteria published by the CAP (Table 2) [6].
The contributing causes of unsatisfactory results in 2009 and 2010
are compared with CAP overall PT Surveys of discordant results
[6].
QA/QC Activities
In order to improve the PT performance for the calendar year
2010, the following GCLP and quality systems measures were
taken:
Methodological errors. We consulted users of various
chemistry equipments in our countries and evaluated their
performance in PT schemes, ease of use and maintenance prior
to the purchase of new equipment. Uninterruptible Power Supply
(UPS) systems were installed for all equipment to ensure stable
power during operation. Subsequently, installation qualification
(IQ), operator qualification (OQ) and performance qualification
(PQ) were performed. The equipment qualification processes
ensure that equipment is installed properly, operates as intended
by the manufacturer, and continues to be suitable for its intended
use. The procedures carried out IQ, OQ, and PQ included inter-
equipment comparison, linearity, reproducibility & repeatability
(R&R) and stability of control materials. Standard operating
procedures for using and maintaining the equipment were
prepared using information in the user manuals. Users were given
adequate training on operation and user maintenance. A full-time
biomedical engineer was employed for servicing the equipment.
Levy-Jennings charts were reviewed to determine the proper
frequency of calibration intervals. To ensure reagents used for our
analysis were properly stored, surprise visits were paid to the
suppliers and the importance of storing reagents at the required
temperatures was explained to them.
Clerical errors. We designed a process to verify clerical
entries prior to final approval of PT results. The results were
transcribed from instrument print outs to the PT answer sheet by
one of the laboratory staff. Then a second laboratory staff will
record the results from the answer sheet to the CAP website.
Subsequently, the unit head or designee reviewed the entered
results against the instrument print-outs.
Laboratory staff were advised to (1) select appropriate reagents,
instrument and method codes; and to modify them if change of
reagent, instrument or method occurred before the next PT
shipment, (2) select the correct unit of measurement for each result
entered, (3) select the correct code if the laboratory is not able to
perform testing due to instrument malfunction or reagents
shortage, and (4) ask for extension in rare occasions when the
laboratory is not able to meet the deadline.
Technical errors. A one-week refresher training on prepa-
ration of quality blood smears and identification of blood parasites
was organized for all of our centers at the Malaria Diagnostic
Center, KHRC in Ghana. The malaria diagnostic center of
KHRC was established as a center of excellence in 2008 as
collaboration between KHRC, the Walter Reed project (Kenya)
and the Malaria Clinical Trials Alliance (MCTA). KHRC
conducted this training for the other centers before the first
survey for blood parasites was received in 2010. During the
training, microscopists shared their SOPs and discussed many
issues related to malaria microscopy, such as QA/QC in the
collection and preparation of blood smears, parasite identification
and quantification. Pre- and post- test performances for each
microscopist were evaluated.
The need to follow specimen handling instructions that come
with the PT kit, use of calibrated pipettes and high purity water in
preparation of chemistry reagents, calibrators and control
materials was discussed with laboratory staff. For quantitative
tests, we monitored the standard deviation index (SDI) from the
PT summary and Participants’ Summary in relation to our test
results. We aimed at having the SDI as close as possible to zero
and our QC results as close as possible to the mean. If both SDI
and QC results indicate high or low results then calibration or
adjusting the calibration factor can resolve the issue. A high QC/
SDI result means a QC value above +1SD and all five PT samples
yielding positive SDI. A negative QC/SDI means a QC value
below -1SD and all five PT samples yielding a negative SDI.
However, if there was a positive SDI with a low QC results, the
biomedical engineer and supplier were consulted, and they
performed careful investigation. With the blood parasites PT, we
redistributed misidentified slides or photographs to the micro-
socopists after grading of the challenge to allow them to have a
second look. The participants’ summary discussion was used as an
in-service training aid.
GCLP Improved PT Performance
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Extensive reviews of the user manuals for our equipment were
performed. In addition, SOPs for the maintenance and daily
operation of the equipment were written and made available to all
personnel.
PT stability. Our laboratories communicated with the
airport officials the importance of keeping our samples at
acceptable temperature during the paperwork clearance process.
Moreover, if a shipment did not arrive within five days of the
scheduled shipping date, a follow up process would be initiated.
Table 1. PT investigation aid.
Checklist of items for possible review
1 - Instrument printouts/sheet agrees with submitted information?
2 - Correct unit of measurement and decimal point?
3 - Correct user group/method listed on submitted information/report?
4 - Previous PT results show similar problem/shifts/trends?
5 - QC result for 1 month before and after PT event show evidence of problems/shifts/trends?
6 - QC record show changes of reagents, lot numbers or controls around the time of the survey?
7 - Reagent and controls within expiration date?
8 - Any other failures in this set?
9 - Any training needs identified during discussion?
10 - PT materials were retested and found to be accepted?
11 - Consultation with manufacture indicates matrix effect on the samples?
12 - Tech. re-read SOP (test method + Q.C procedure + reagent Handling) to confirm test method validity?
13 - Follow maintenance table?
14 - Last linearity of device was accepted?
15 - PT materials investigation (handling, storage, analysis sequence, re-constitution and matrix effect)?
doi:10.1371/journal.pone.0039098.t001
Table 2. Classification of errors.
Error Cause(s)
Clerical 1 - Erroneous transcription of results from an instrument print-out or manual log
2 - Reporting an incorrect unit of Measurement
3 - Reporting of an incorrect method or instrument
4 - Misplacement of a decimal point
5 - The selection of an incorrect reporting code
Methodological 1 - Inappropriate use of QC materials
2 - Using QC limits that are too wide
3 - SOP lack guidance on frequency of calibration
4 - Instrument used without performing test method validation
5 - Reagent problems
6 - Poorly written SOPs
7 - Procedure not in accordance with current standard of practice
8 - Lot-to-lot variation
9 - Inadequate maintenance
Technical 1 - Inappropriate sample handling
2 - Failure to calibrate pipettes
3 - Inappropriate dilution
4 - Water quality issues
5 - Improper reconstitution, preparation or mixing of PT materials
6 - Microscopic misinterpretation
Stability of PT 1 - Improper storage conditions and/or delay in receiving
Random 1 - Any error that does not fall into any of the above categories
doi:10.1371/journal.pone.0039098.t002
GCLP Improved PT Performance
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Usually, the PT vendor provided our laboratories with a tracking
number to locate the shipment during transit. Once the shipment
arrived, it would be analyzed as soon as possible.
Random errors. When all the aforementioned causes of
errors were excluded, we would classify the cause of failure as
random error, especially when repeat testing indicated an
acceptable performance. Our laboratories would not perform
any corrective actions when random error was identified.
Adjusting the testing system due to random errors can lead to
future failures.
Results
Methodological errors accounted for the majority of unsatisfac-
tory results for both years in our laboratories (Figure 1). There was
a 33% increase in PT conducted by the four centers (24 in 2009,
32 in 2010), and therefore more opportunities for error. However,
despite the increase in testing, there was a 12% decrease in the
absolute number of errors, from 180 in 2009 to 159 in 2010, and
the error rate per survey decreased by 35%. The greatest
reduction in the number errors was for clerical errors, from 31
errors in 2009 to 10 errors in 2010, while methodological errors
decreased from 131 to 115 (Table 3). Most of the methodological
errors were from quantitative test results. The majority of
quantitative errors occurs due to inappropriate or lack of
calibration. However, while there was no error due to PT stability
in 2009, this increased to 16% (n= 25) in 2010 (Table 3). Overall,
the error rate per survey dropped from 7.5 error/survey (180/24)
in 2009 to 4.9 errors/survey (159/32) in 2010, a 35% reduction.
PT survey success rate in 2009 was 58% (14 of 24 PT
shipments) while in 2010 the rate increased to 88% (28 of 32 PT
shipments) (Table 4). Average performance scores for all centers in
2009 and 2010 (Figure 2) were 77% and 90%, respectively (CAP
cutoff for satisfactory results is 80%). Site-specific average
performances are shown in Figure 2.
Figure 3 shows how each site performed in the different areas of
testing in 2009 and 2010. Apart from the chemistry PT for
NHRC, all other centers recorded an average score of more than
80% in the 2010 PTs, an improvement over the previous year’s
performance. There was no data for KHRC in 2009 because
testing began 2010.
Figure 4 shows the average correct identification of malaria
parasites, other blood parasites, and negative slides for all sites.
Both malaria parasites and the other blood parasites improved
significantly between 2009 and 2010 (57% to 83% and 56% to
86% respectively). All negative slides were identified correctly in
both years.
Our surprise visits to reagent suppliers revealed poor storage
conditions. Of the four suppliers visited, only one had temperature
records. The recorded temperatures for the refrigerators were
higher than the recommended 2–8uC due to overloading of the
refrigerators. Room temperatures were higher than the recom-
mended 20–25uC, as there was no air-conditioning in the reagent
storage rooms.
Discussion
Investigating causes of unsatisfactory performance and the
immediate application of interventions are crucial steps in
preventing future occurrences. Methodological errors were the
major cause of unsatisfactory results in our laboratories. A
previous report from the CAP PT participating laboratories
indicate the possible causes of errors were 51% clerical, 24%
technical, 12% methodological, 7% problem with PT materials,
Figure 1. Comparison of proportion of errors due to each type of error for unsatisfactory results at study centers in 2009, 2010, and
US averages according to CAP data.
doi:10.1371/journal.pone.0039098.g001
Table 3. PT error rates in 2009–2010 for all centers.
Year Methodological Technical Clerical
PT
Stability Random
2009 73% (131) 4% (8) 17% (31) 0 6% (10)
2010 72% (115) 4% (6) 6% (10) 16% (25) 2% (3)
2009/2010
average
73% (246) 4% (14) 12% (41) 7% (25) 4% (13)
CAP (2007) 12% 24% 51% 7% 6%
doi:10.1371/journal.pone.0039098.t003
GCLP Improved PT Performance
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and 6% random errors [6]. These types of errors were
predominantly made in laboratories in the US, with much more
experience in quality measures, and varied significantly from what
we found. In our centers in sub-Saharan Africa, methodological
errors, and not clerical errors, accounted for the vast majority of
errors. We suspect this reflects the lack of experience of many
laboratory staff in developing countries with quality control
methods used in developed countries. Through ongoing training
and evaluation of performance on PT testing, we were able to
decrease the number of methodological errors per PT from 5.5
errors/PT in 2009 to 3.6 errors/PT in 2010, a 35% reduction in
methodological errors.
Specific items that were noted to contribute to failures include
equipment selection, test method validation, equipment mainte-
nance, reagent quality and storage, quality control procedures,
continuing education, availability of expertise, and PT stability.
Each of these items is discussed below:
Equipment Selection
Equipment related problems contributed greatly to the meth-
odological errors. Proper selection and acquisition of the right
equipment is the first step for a successful journey to quality [7].
We often face the dilemma of purchasing open-system equipment
which requires highly skilled staff versus closed system equipment
which often places the laboratory at the mercy of an unreliable
vender to provide reagents on time. According to Petti et al (2006),
only 26% of laboratory staff in Ghana are professionally qualified
[8]. Against this background, we performed extensive user manual
review, technical, and refresher trainings.
Test Method Validation
Once equipment is purchased, laboratories should ensure test
method validation (TMV) is performed. TMV includes accuracy,
precision, analytical sensitivity, analytical specificity, reportable
range, and reference intervals [9]. Unfortunately, in our setting,
the role of suppliers has been limited to the installation and basic
user training. This is similar to what was reported by Crucitti and
colleagues (2010) [2]. It is, however, the responsibility of each
laboratory to ensure the completion and acceptance of TMV prior
to the initiation of patient testing [10].
Equipment Maintenance
Once equipment is installed, laboratories should ensure proper
scheduling, performance and documentation of daily, weekly,
monthly, and other recommended maintenance [9]. Integrating
the user’s manual into the SOP has simplified the steps needed to
accomplish assigned tasks consistently. The presence of the full-
time biomedical engineer ensures proper performance and
monitoring of required maintenance which lessen equipment
downtime. Furthermore, due to fluctuations in the supply of
electricity an un-interruptible power supply system was always
provided.
Reagents
Poor storage and transport of reagents, controls and calibration
materials by suppliers often leads to poor reagent performance
that negatively impact the quality of testing. To eliminate these
effects, our trial centers now procure reagents from reputable
suppliers who showed proper storage condition and documenta-
tion. It is important that laboratories work with suppliers in
improving service performance [11].
Quality Control
QC must be tested and acceptable results obtained prior to
release of patients results [9,12]. All centers were trained in QC
monitoring, real-time plotting of Levy Jennings charts and the
implementation of statistical QC rules [13]. Laboratory supervi-
sors were trained on how to calculate and implement in-house
control values as ranges provided by manufacturers tend to be too
Figure 2. Average PT performance by site.
doi:10.1371/journal.pone.0039098.g002
Table 4. PT Performance in 2009–2010 for all centers.
Year PT success rate Average PT score
2009 58% (14 out of 24 surveys) 77%
2010 88% (28 out of 32 surveys) 90%
doi:10.1371/journal.pone.0039098.t004
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wide [9]. The adaptation of in-house tighter control ranges assisted
our centers in the early detection of accuracy and precision related
problems before it affects participants’ results and/or PT samples.
Continuing Education
Some of the errors encountered in the blood parasites surveys
came from non-malaria organisms such as Babesia, Leishmania, and
microfilaria (pre-larval stage) which are not commonly seen in our
centers. The malaria microscopy refresher training provided
laboratory microscopists from all centers an opportunity for
interaction and experience sharing. Networking and exchange of
information among scientists in resource limited settings is vital
[14]. Scheduling regular refresher training among scientists will
assist our centers to overcome ‘‘intellectual isolation’’ [15].
Improving accuracy of malaria microscopy can avert the recent
trend of Ghanaian physicians who use empirical methods to
diagnose malaria [16].
QA/QC Expertise
The presence of a QA/QC advisor provided the centers with
the hands-on technical support needed during clinical trials. Most
of the supervisors in resource limited settings lack the technical
expertise necessary to ensure accuracy of test results [8]. It is
obvious that establishing a quality assurance program will increase
the trial budget [2]. However, these activities will ensure the safety
of participants, accuracy of testing and subsequently improve
Figure 3. Performance by Center for 2009 and 2010 for blood parasites, chemistry and hematology.
doi:10.1371/journal.pone.0039098.g003
Figure 4. Average correct identification of the blood parasites surveys for all sites.
doi:10.1371/journal.pone.0039098.g004
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healthcare in resource limited settings [2]. According to Simon
[17], programs measure their success by factors such as: the
number of publications, work cited, number of funded studies, and
number of scientist trained. Sustaining successful performance in
proficiency testing should be used as a direct indicator of the
quality of laboratory performance.
PT Stability
We did not experience unsatisfactory performance as a result of
unsuitable PT samples in 2009. This was, however, a significant
contributing factor to the errors encountered in 2010. The PT
stability error rate was about two times the value of the CAP data.
Issues with PT survey materials stability are common in
international laboratories. Many times the PT materials travel
through several airports and warehouses before they arrive at their
final destination. The temperature during the travel is not
monitored and/or controlled. Some of the PT materials will
require customs clearance before or after its arrival. Ensuring
proper storage conditions during the paperwork processing is
crucial to the stability of the PT materials. Some postal carriers,
who lack refrigeration facilities at the airport, can accept
refrigerators donated by laboratories to be used for storage of
their shipment. However, this step will require a complete
understanding from the postal carriers of the importance of
compliance with temperature requirements. Laboratories should
monitor the shipping calendar closely. Any delays of samples
testing can negatively impact the quality of results. International
laboratories do not have to order the PT product with less than ten
days of stability [18]. The PT ordering booklet contains the list of
tests with less than ten days shelf life. An alternative assessment
should be performed instead [19].
Conclusion
The intervention impact has been positive. All our centers had a
higher average performance score in 2010 compared to that of
2009. KHRC did not have scores for 2009 because participation
in the PT surveys started in 2010.
Improving the performance of laboratories in PT is a
continuous process. Through a continuous program of education
and training described above, we were able to achieve a 35%
reduction in errors over the course of a year. However, despite a
35% reduction in methodological errors, this type of error remains
the most common cause of errors at the four clinical trial centers in
sub-Saharan Africa, accounting for 73% of errors. Comparing this
rate to the US rate of methodological errors of 12%, emphasizes
the need for more training of laboratory staff in this region in
quality control methods that are well established in developed
countries. Our centers will continue to use PT to improve Quality
Assurance practices in our laboratories. We look forward to a
continuous improvement process and sharing our experiences with
other laboratories in the region.
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